Implementation of a symptom-triggered benzodiazepine protocol for alcohol withdrawal in family medicine inpatients

Hospital Pharmacy

Volumn 44, Issue 10, 2009, Pages 881-887

  See, Sharon ^a,b   Nosal, Sarah ^c   Barr, Wendy Brooks ^b,d   Schiller, Robert ^d,e  

^a ST JOHN'S UNIVERSITY   (United States)

^b Institute for Urban Family Health   (United States)

^c Family Physician   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e Department of Family Medicine   (United Kingdom)

Author keywords

Alcohol withdrawal; Benzodiazepines; Symptom triggered therapy

Indexed keywords

ALCOHOL; BENZODIAZEPINE; CHLORDIAZEPOXIDE; DIAZEPAM; LORAZEPAM; OXAZEPAM; PHENOBARBITAL;

ABSENCE OF SIDE EFFECTS; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL SCALE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DRUG ABUSE; DRUG EFFICACY; DRUG SAFETY; FAMILY MEDICINE; FEASIBILITY STUDY; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOSPITAL PATIENT; HUMAN; HYPONATREMIA; LENGTH OF STAY; NAUSEA; PALLIATIVE THERAPY; PILOT STUDY; RATING SCALE; RETROSPECTIVE STUDY; REVIEW; SEDATION; SIDE EFFECT; SYMPTOM; THORAX PAIN; TREATMENT OUTCOME; VOMITING; WITHDRAWAL SEIZURE; WITHDRAWAL SYNDROME;

EID: 75149150941     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4410-881     Document Type: Review

References (12)

1. National Institute on Alcohol Abuse and Alcoholism. Twelve month prevalence and population estimates of DSM-IV alcohol dependence by age, sex, and race-ethinicity; United States, 2001-2002. http://www .niaaa.nih.gov/ Resources/DatabaseResour ces/QuickFacts/AlcoholDependence/abus dep2.htm. Accessed September 26, 2008.
2. Gold J, Nelson LS. Ethanol withdrawal. In: Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS, eds. Goldfrank's Toxicologic Emergencies. 8th ed. New York, NY: The McGraw-Hill Companies Inc; 2006: 1167-1175.
3. Caetano R, Clark CL, Greenfield TK. Prevalence, trends, and incidence of alcohol withdrawal symptoms: analysis of general population and clinical samples. Alcohol Health Res World. 1998;22 (1):73-79.
4. Kasser CL, Geller A, Howell E, Wartenberg A. Principles of detoxification. In: Graham AW, Schultz TK, eds. Priniciples of Addiction Medicine. 2nd ed. Chevy Chase, MD: American Society of Addiction Medicine Inc; 1998:423-430.
5. Rodgers JE, Crouch MA. Phenobarbital for alcohol withdrawal syndrome. Am J Health Syst Pharm. 1999;56(2): 175-178.
6. Ntais C, Pakos E, Kyzas P, Ioannidis JP. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2005;(3): CD005063.
7. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A metaanalysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA. 1997;278(2):144-151.
8. McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry. 2008;79(8):854-862.
9. Wilson A, Vulcano B. A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome. Alcohol Clin Exp Res. 1984; 8(6):542-545.
10. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353-1357.
11. Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med. 2002;162(10): 1117-1121.
12. Roffman JL, Stern TA. Alcohol withdrawal in the setting of elevated blood alcohol levels. Prim Care Companion J Clin Psychiatry. 2006;8(3):170-173.